Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-12-07 07:51 |
Pharming announces completion of financing for RUCONEST® North American Rights …
|
English | 147.8 KB | ||
| 2016-11-22 08:09 |
Pharming Launches Rights Issue to raise €12.1 million as part of RUCONEST® Nort…
|
English | 127.4 KB | ||
| 2016-11-21 08:51 |
Pharming Announces Financing Plans for Closing of RUCONEST® North American Righ…
|
English | 68.7 KB | ||
| 2016-11-14 16:51 |
Pharming Announces the Presentation of the Results of the RUCONEST® Phase II St…
|
English | 366.6 KB | ||
| 2016-11-14 08:33 |
Pharming announces update on financing
|
English | 142.6 KB | ||
| 2016-11-11 10:50 |
CHMP Adopts Positive Opinion to Include Self-administration for RUCONEST®
|
English | 523.7 KB | ||
| 2016-10-31 11:06 |
Pharming Reports on Financial Results for the First Nine Months of 2016
|
English | 594.6 KB | ||
| 2016-10-06 07:25 |
Pharming Reports on Extraordinary General Meeting of Shareholders
|
English | 336.8 KB | ||
| 2016-10-03 08:35 |
Pharming Reports on Financial Results for the First Eight Months of 2016
|
English | 588.4 KB | ||
| 2016-08-23 08:11 |
Pharming Convene an Extraordinary General Meeting of Shareholders
|
English | 488.6 KB | ||
| 2016-08-09 14:34 |
Pharming Announces Acquisition of all North American Commercialisation Rights t…
|
English | 465.5 KB | ||
| 2016-07-28 09:05 | English | 835.6 KB | |||
| 2016-07-18 08:35 |
Pharming Announces Positive Results from Randomized Controlled Trial with RUCON…
|
English | 341.9 KB | ||
| 2016-07-14 07:33 |
PHARMING Amends RUCONEST Distribution Agreement with SOBI
|
English | 329.5 KB | ||
| 2016-05-26 08:20 |
Pharming Reports on Annual General Meeting of Shareholders Pharming's Board of …
|
English | 207.8 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
